National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment

Hepatology International · Published 2026-08-03 · DOI 10.1007/s12072-026-11135-y

Free full text

Authors (7)

Phunchai Charatcharoenwitthaya, Tawesak Tanwandee, Pisit Tangkijvanich, Teerha Piratvisuth, Chatree Jullapetch, Cheewanan Lertpiriyasuwat, Pongtorn Chartpitak

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Charatcharoenwitthaya, P., Tanwandee, T., Tangkijvanich, P., et al. (2026). National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment. Hepatology International. https://doi.org/10.1007/s12072-026-11135-y

Related articles

• APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update · Hepatology International · 2026 · Cites or is cited by this article · Same journal
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis · Clinics in Liver Disease · 2026 · Cites or is cited by this article
• Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection (Text Extract): Executive Summary. · 2025 · Cites or is cited by this article
• Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease · Hepatology International · 2026 · Same journal
• APASL STC on Wilson Disease; New Delhi 2026 · Hepatology International · 2026 · Same journal
• Tolvaptan for hyponatremia in patients with cirrhosis: a post hoc subgroup analysis of a multicenter, randomized, double-blind, placebo-controlled trial · Hepatology International · 2026 · Same journal
• Phosphatidylethanol versus clinical criteria to diagnose alcohol use relapse after liver transplantation: a prospective cohort study · Hepatology International · 2026 · Same journal
• Precision medicine for G-CSF in ACLF: the biomarker gap · Hepatology International · 2026 · Same journal
• Response to letter to editor—Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon · Hepatology International · 2026 · Same journal
• Methodological Considerations in the MAFLD-MASLD Dichotomy for Cardiac Risk Assessment · Hepatology International · 2026 · Same journal